Differential expression of cannabinoid receptors in the human colon: Cannabinoids promote epithelial wound healing

Gastroenterology

Volumn 129, Issue 2, 2005, Pages 437-453

  Wright, Karen ^a   Rooney, Nicholas ^b   Feeney, Mark ^c   Tate, Jeremy ^c   Robertson, Duncan ^c   Welham, Melanie ^a   Ward, Stephen ^a  

^a University of Bath   (United Kingdom)

^b SOUTHMEAD HOSPITAL   (United Kingdom)

^c ROYAL UNITED HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 1 DEOXY 3 (1,1 DIMETHYLBUTYL) DELTA8 TETRAHYDROCANNABINOL; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; CANNABINOID; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABINOID DERIVATIVE; CANNABINOID RECEPTOR; CYCLOPROPANE DERIVATIVE; LYSOPHOSPHATIDIC ACID; UNCLASSIFIED DRUG;

ARTICLE; COLON MUCOSA; CONTROLLED STUDY; DRUG RECEPTOR BINDING; ENTERITIS; EPITHELIUM; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN VITRO STUDY; LAMINA PROPRIA; MACROPHAGE; MYENTERIC PLEXUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE; TISSUE DISTRIBUTION; WOUND CLOSURE; WOUND HEALING;

EID: 23244457833     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gastro.2005.05.026     Document Type: Article

References (79)

1. Y. Gaoni, R. Mechoulam Isolation, structure and partial synthesis of an active constituent of hashish J Am Chem Soc 86 1964 1646 1647
2. W.A. Devane, F.A. Dysarz 3rd, M.R. Johnson, L.S. Melvin, A.C. Howlett Determination and characterization of a cannabinoid receptor in rat brain Mol Pharmacol 34 1988 605 613
3. L.A. Matsuda, S.J. Lolait, M.J. Brownstein, A.C. Young, T.I. Bonner Structure of a cannabinoid receptor and functional expression of the cloned cDNA Nature 346 1990 561 564
4. S. Munro, K.L. Thomas, M. Abu-Shaar Molecular characterization of a peripheral receptor for cannabinoids Nature 365 1993 61 65
5. R. Mechoulam, S. Ben-Shabat, L. Hanus, M. Ligumsky, N.E. Kaminski, A.R. Schatz, A. Gopher, S. Almog, B.R. Martin, D.R. Compton Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors Biochem Pharmacol 50 1995 83 90
6. T. Sugiura, S. Kondo, A. Sukagawa, S. Nakane, A. Shinoda, K. Itoh, A. Yamashita, K. Waku 2-arachidonoylglycerol a possible endogenous cannabinoid receptor ligand in brain Biochem Biophys Res Commun 215 1995 89 97
7. L. Hanus, S. Abu-Lafi, E. Fride, A. Breuer, Z. Vogel, D.E. Shalev, I. Kustanovich, R. Mechoulam 2-arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor Proc Natl Acad Sci U S A 98 2001 3662 3665
8. A.C. Porter, J.M. Sauer, M.D. Knierman, G.W. Becker, M.J. Berna, J. Bao, G.G. Nomikos, P. Carter, F.P. Bymaster, A.B. Leese, C.C. Felder Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor J Pharmacol Exp Ther 301 2002 1020 1024
9. C.J. Fowler, S.O. Jacobsson Cellular transport of anandamide, 2-arachidonoylglycerol and palmitoylethanolamide-targets for drug development? Prostaglandins Leukot Essent Fatty Acids 66 2002 193 200
10. T. Sugiura, Y. Kobayashi, S. Oka, K. Waku Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance Prostaglandins Leukot Essent Fatty Acids 66 2002 173 192
11. K.R. Kozak, L.J. Marnett Oxidative metabolism of endocannabinoids Prostaglandins Leukot Essent Fatty Acids 66 2002 211 220
12. H.H. Schmid, E.V. Berdyshev Cannabinoid receptor-inactive N-acylethanolamines and other fatty acid amides metabolism and function Prostaglandins Leukot Essent Fatty Acids 66 2002 363 376
13. Merck Manual of the materia medica 1899 Merck Rahway, NJ
14. L. Grinspoon, J.B. Bakalar Marijuana-the forbidden medicine 1997 Yale University Press New Haven, CT
15. W.L. Dewey, L.S. Harris, J.S. Kennedy Some pharmacological and toxicological effects of 1-trans- 8 and 1-trans-9-tetrahydrocannabinol in laboratory rodents Arch Int Pharmacodyn Ther 196 1972 133 145
16. I.M. Coupar, D.A. Taylor Effect of delta 9-tetrahydrocannabinol on prostaglandin concentrations and fluid absorption rates in the rat small intestine J Pharm Pharmacol 35 1983 392 394
17. R.D. Sofia, W. Diamantis, J. Edelson Effect of delta9- tetrahydrocannabinol on the gastrointestinal tract of the rat Pharmacology 17 1978 79 82
18. G.B. Chesher, C.J. Dahl, M. Everingham, D.M. Jackson, H. Marchant-Williams, G.A. Starmer The effect of cannabinoids on intestinal motility and their antinociceptive effect in mice Br J Pharmacol 49 1973 588 594
19. A. Kulkarni-Narla, D.R. Brown Localization of CB1-cannabinoid receptor immunoreactivity in the porcine enteric nervous system Cell Tissue Res 302 2000 73 80
20. A.A. Coutts, A.J. Irving, K. Mackie, R.G. Pertwee, S. Anavi-Goffer Localisation of cannabinoid CB(1) receptor immunoreactivity in the guinea pig and rat myenteric plexus J Comp Neurol 448 2002 410 422
21. M.A. Casu, A. Porcella, S. Ruiu, P. Saba, G. Marchese, M.A. Carai, R. Reali, G.L. Gessa, L. Pani Differential distribution of functional cannabinoid CB1 receptors in the mouse gastroenteric tract Eur J Pharmacol 459 2003 97 105
22. W.K. MacNaughton, M.D. Van Sickle, C.M. Keenan, K. Cushing, K. Mackie, K.A. Sharkey Distribution and function of the cannabinoid-1 receptor in the modulation of ion transport in the guinea pig ileum relationship to capsaicin-sensitive nerves Am J Physiol Gastrointest Liver Physiol 286 2004 G863 G871
23. M. Storr, A. Sibaev, G. Marsicano, B. Lutz, V. Schusdziarra, J.P. Timmermans, H.D. Allescher Cannabinoid receptor type 1 modulates excitatory and inhibitory neurotransmission in mouse colon Am J Physiol 286 2004 G110 G117
24. T. Croci, L. Manara, G. Aureggi, F. Guagnini, M. Rinaldi-Carmona, J.P. Maffrand, G. Le Fur, S. Mukenge, G. Ferla In vitro functional evidence of neuronal cannabinoid CB1 receptors in human ileum Br J Pharmacol 125 1998 1393 1395
25. L. Pinto, A.A. Izzo, M.G. Cascio, T. Bisogno, K. Hospodar-Scott, D.R. Brown, N. Mascolo, V. Di Marzo, F. Capasso Endocannabinoids as physiological regulators of colonic propulsion in mice Gastroenterology 123 2002 227 234
26. A.A. Izzo, F. Fezza, R. Capasso, T. Bisogno, L. Pinto, T. Iuvone, G. Esposito, N. Mascolo, V. Di Marzo, F. Capasso Cannabinoid CB1-receptor mediated regulation of gastrointestinal motility in mice in a model of intestinal inflammation Br J Pharmacol 134 2001 563 570
27. D.C. McVey, P.C. Schmid, H.H. Schmid, S.R. Vigna Endocannabinoids induce ileitis in rats via the capsaicin receptor (VR1) J Pharmacol Exp Ther 304 2003 713 722
28. A. Ligresti, T. Bisogno, I. Matias, L. De Petrocellis, M.G. Cascio, V. Cosenza, G. D'Argenio, G. Scaglione, M. Bifulco, I. Sorrentini, V. Di Marzo Possible endocannabinoid control of colorectal cancer growth Gastroenterology 125 2003 677 687
29. L. Manara, T. Croci, F. Guagnini, M. Rinaldi-Carmona, J.P. Maffrand, G. Le Fur, S. Mukenge, G. Ferla Functional assessment of neuronal cannabinoid receptors in the muscular layers of human ileum and colon Dig Liver Dis 34 2002 262 269
30. N. Mascolo, A.A. Izzo, A. Ligresti, A. Costagliola, L. Pinto, M.G. Cascio, P. Maffia, A. Cecio, F. Capasso, V. Di Marzo The endocannabinoid system and the molecular basis of paralytic ileus in mice FASEB J 16 2002 1973 1975
31. M. Landi, T. Croci, M. Rinaldi-Carmona, J.P. Maffrand, G. Le Fur, L. Manara Modulation of gastric emptying and gastrointestinal transit in rats through intestinal cannabinoid CB(1) receptors Eur J Pharmacol 450 2002 77 83
32. A.A. Izzo, F. Capasso, A. Costagliola, T. Bisogno, G. Marsicano, A. Ligresti, I. Matias, R. Capasso, L. Pinto, F. Borrelli, A. Cecio, B. Lutz, N. Mascolo, V. Di Marzo An endogenous cannabinoid tone attenuates cholera toxin-induced fluid accumulation in mice Gastroenterology 125 2003 765 774
33. M. Begg, N. Dale, E. Llaudet, A. Molleman, M.E. Parsons Modulation of the release of endogenous adenosine by cannabinoids in the myenteric plexus-longitudinal muscle preparation of the guinea-pig ileum Br J Pharmacol 137 2002 1298 1304
34. C.F. Mang, D. Erbelding, H. Kilbinger Differential effects of anandamide on acetylcholine release in the guinea-pig ileum mediated via vanilloid and non-CB1 cannabinoid receptors Br J Pharmacol 134 2001 161 167
35. S. Galiegue, S. Mary, J. Marchand, D. Dussossoy, D. Carriere, P. Carayon, M. Bouaboula, D. Shire, G. Le Fur, P. Casellas Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations Eur J Biochem 232 1995 54 61
36. G. Griffin, S.R. Fernando, R.A. Ross, N.G. McKay, M.L. Ashford, D. Shire, J.W. Huffman, S. Yu, J.A. Lainton, R.G. Pertwee Evidence for the presence of CB2-like cannabinoid receptors on peripheral nerve terminals Eur J Pharmacol 339 1997 53 61
37. R. Mathison, W. Ho, Q.J. Pittman, J.S. Davison, K.A. Sharkey Effects of cannabinoid receptor-2 activation on accelerated gastrointestinal transit in lipopolysaccharide-treated rats Br J Pharmacol 142 2004 1247 1254
38. E.V. Berdyshev Cannabinoid receptors and the regulation of immune response Chem Phys Lipids 108 2000 169 190
39. M.D. Roth, G.C. Baldwin, D.P. Tashkin Effects of delta-9- tetrahydrocannabinol on human immune function and host defense Chem Phys Lipids 121 2002 229 239
40. N.R. Bhat, P. Zhang, E.L. Hogan Thrombin activates mitogen-activated protein kinase in primary astrocyte cultures J Cell Physiol 165 1995 417 424
41. M. Bouaboula, C. Poinot-Chazel, B. Bourrie, X. Canat, B. Calandra, M. Rinaldi-Carmona, G. Le Fur, P. Casellas Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1 Biochem J 312 1995 637 641
42. M. Bouaboula, S. Perrachon, L. Milligan, X. Canat, M. Rinaldi-Carmona, M. Portier, F. Barth, B. Calandra, F. Pecceu, J. Lupker, J.P. Maffrand, G. Le Fur, P. Casellas A selective inverse agonist for central cannabinoid receptor inhibits mitogen-activated protein kinase activation stimulated by insulin or insulin-like growth factor 1. Evidence for a new model of receptor/ligand interactions J Biol Chem 272 1997 22330 22339
43. T. Gomez del Pulgar, G. Velasco, M. Guzman The CB1 cannabinoid receptor is coupled to the activation of protein kinase B/Akt Biochem J 347 2000 369 373
44. E. Molina-Holgado, J.M. Vela, A. Arevalo-Martin, G. Almazan, F. Molina-Holgado, J. Borrell, C. Guaza Cannabinoids promote oligodendrocyte progenitor survival involvement of cannabinoid receptors and phosphatidylinositol-3 kinase/Akt signaling J Neurosci 22 2002 9742 9753
45. C. Sutherland, I.A. Leighton, P. Cohen Inactivation of glycogen synthase kinase-3 beta by phosphorylation new kinase connections in insulin and growth-factor signalling Biochem J 296 1993 15 19
46. C. Sutherland, P. Cohen The alpha-isoform of glycogen synthase kinase-3 from rabbit skeletal muscle is inactivated by p70 S6 kinase or MAP kinase-activated protein kinase-1 in vitro FEBS Lett 338 1994 37 42
47. D.A. Cross, D.R. Alessi, P. Cohen, M. Andjelkovich, B.A. Hemmings Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B Nature 378 1995 785 789
48. P.R. Wheater, H.G. Burkitt, and V.G. Daniels Functional histology 1979 Churchill Livingstone London, UK
49. F. Massa, G. Marsicano, H. Hermann, A. Cannich, K. Monory, B.F. Cravatt, G.L. Ferri, A. Sibaev, M. Storr, B. Lutz The endogenous cannabinoid system protects against colonic inflammation J Clin Invest 113 2004 1202 1209
50. D.A. Pettit, M.P. Harrison, J.M. Olson, R.F. Spencer, G.A. Cabral Immunohistochemical localization of the neural cannabinoid receptor in rat brain J Neurosci Res 51 1998 391 402
51. C. Song, A.C. Howlett Rat brain cannabinoid receptors are N-linked glycosylated proteins Life Sci 56 1995 1983 1989
52. P. Carayon, J. Marchand, D. Dussossoy, J.M. Derocq, O. Jbilo, A. Bord, M. Bouaboula, S. Galiegue, P. Mondiere, G. Penarier, G.L. Fur, T. Defrance, P. Casellas Modulation and functional involvement of CB2 peripheral cannabinoid receptors during B-cell differentiation Blood 92 1998 3605 3615
53. C.A. Rouzer, K. Ghebreselasie, L.J. Marnett Chemical stability of 2-arachidonylglycerol under biological conditions Chem Phys Lipids 119 2002 69 82
54. D.K. Podolsky Inflammatory bowel disease N Engl J Med 347 2002 417 429
55. A. Sturm, A.U. Dignass Modulation of gastrointestinal wound repair and inflammation by phospholipids Biochim Biophys Acta 1582 2002 282 288
56. A. Sturm, T. Sudermann, K.M. Schulte, H. Goebell, A.U. Dignass Modulation of intestinal epithelial wound healing in vitro and in vivo by lysophosphatidic acid Gastroenterology 117 1999 368 377
57. D. Shida, J. Kitayama, H. Yamaguchi, Y. Okaji, N.H. Tsuno, T. Watanabe, Y. Takuwa, H. Nagawa Lysophosphatidic acid (LPA) enhances the metastatic potential of human colon carcinoma DLD1 cells through LPA1 Cancer Res 63 2003 1706 1711
58. A. Calignano, G. La Rana, A. Makriyannis, S.Y. Lin, M. Beltramo, D. Piomelli Inhibition of intestinal motility by anandamide, an endogenous cannabinoid Eur J Pharmacol 340 1997 R7 R8
59. A.A. Izzo, N. Mascolo, L. Pinto, R. Capasso, F. Capasso The role of cannabinoid receptors in intestinal motility, defaecation and diarrhoea in rats Eur J Pharmacol 384 1999 37 42
60. D. Cota, G. Marsicano, B. Lutz, V. Vicennati, G.K. Stalla, R. Pasquali, U. Pagotto Endogenous cannabinoid system as a modulator of food intake Int J Obes Relat Metab Disord 27 2003 289 301
61. L. Pinto, R. Capasso, G. Di Carlo, A.A. Izzo Endocannabinoids and the gut Prostaglandins Leukot Essent Fatty Acids 66 2002 333 341
62. R. Gomez, M. Navarro, B. Ferrer, J.M. Trigo, A. Bilbao, I. Del Arco, A. Cippitelli, F. Nava, D. Piomelli, F. Rodriguez de Fonseca A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding J Neurosci 22 2002 9612 9617
63. T. Croci, M. Landi, A.M. Galzin, P. Marini Role of cannabinoid CB1 receptors and tumor necrosis factor-alpha in the gut and systemic anti-inflammatory activity of SR 141716 (Rimonabant) in rodents Br J Pharmacol 140 2003 115 122
64. A. Swidsinski, A. Ladhoff, A. Pernthaler, S. Swidsinski, V. Loening-Baucke, M. Ortner, J. Weber, U. Hoffmann, S. Schreiber, M. Dietel, H. Lochs Mucosal flora in inflammatory bowel disease Gastroenterology 122 2002 44 54
65. A. Panja, E. Siden, L. Mayer Synthesis and regulation of accessory/proinflammatory cytokines by intestinal epithelial cells Clin Exp Immunol 100 1995 298 305
66. K. Ihenetu, A. Molleman, M.E. Parsons, C.J. Whelan Inhibition of interleukin-8 release in the human colonic epithelial cell line HT-29 by cannabinoids Eur J Pharmacol 458 2003 207 215
67. Y.R. Mahida, M. Ceska, F. Effenberger, L. Kurlak, I. Lindley, C.J. Hawkey Enhanced synthesis of neutrophil-activating peptide-1/interleukin-8 in active ulcerative colitis Clin Sci (Lond) 82 1992 273 275
68. M.G. Sanchez, L. Ruiz-Llorente, A.M. Sanchez, I. Diaz-Laviada Activation of phosphoinositide 3-kinase/PKB pathway by CB(1) and CB(2) cannabinoid receptors expressed in prostate PC-3 cells. Involvement in Raf-1 stimulation and NGF induction Cell Signal 15 2003 851 859
69. M.T. Samson, A. Small-Howard, L.M. Shimoda, M. Koblan-Huberson, A.J. Stokes, H. Turner Differential roles of CB1 and CB2 cannabinoid receptors in mast cells J Immunol 170 2003 4953 4962
70. C. Shi, A. Szczesniak, L. Mao, C. Jollimore, M. Coca-Prados, O. Hung, M.E. Kelly A3 adenosine and CB1 receptors activate a PKC-sensitive Cl- current in human nonpigmented ciliary epithelial cells via a G beta gamma-coupled MAPK signaling pathway Br J Pharmacol 139 2003 475 486
71. B.L. Upham, A.M. Rummel, J.M. Carbone, J.E. Trosko, Y. Ouyang, R.B. Crawford, N.E. Kaminski Cannabinoids inhibit gap junctional intercellular communication and activate ERK in a rat liver epithelial cell line Int J Cancer 104 2003 12 18
72. R.G. Pertwee Inverse agonism and neutral antagonism at cannabinoid CB(1) receptors Life Sci 76 2005 1307 1324
73. G.J. Molderings, H. Bonisch, R. Hammermann, M. Gothert, M. Bruss Noradrenaline release-inhibiting receptors on PC12 cells devoid of alpha(2(-)) and CB(1) receptors similarities to presynaptic imidazoline and edg receptors Neurochem Int 40 2002 157 167
74. M. Bouaboula, N. Desnoyer, P. Carayon, T. Combes, P. Casellas Gi protein modulation induced by a selective inverse agonist for the peripheral cannabinoid receptor CB2 implication for intracellular signalization cross-regulation Mol Pharmacol 55 1999 473 480
75. C.R. Hiley, W.R. Ford Cannabinoid pharmacology in the cardiovascular system potential protective mechanisms through lipid signalling Biol Rev Camb Philos Soc 79 2004 187 205
76. Y. Matsubayashi, M. Ebisuya, S. Honjoh, E. Nishida ERK activation propagates in epithelial cell sheets and regulates their migration during wound healing Curr Biol 14 2004 731 735
77. M.S. Roberts, A.J. Woods, P.E. Shaw, J.C. Norman ERK1 associates with alpha(v)beta 3 integrin and regulates cell spreading on vitronectin J Biol Chem 278 2003 1975 1985
78. M.S. Roberts, A.J. Woods, T.C. Dale, P. Van Der Sluijs, J.C. Norman Protein kinase B/Akt acts via glycogen synthase kinase 3 to regulate recycling of alpha v beta 3 and alpha 5 beta 1 integrins Mol Cell Biol 24 2004 1505 1515
79. S. Etienne-Manneville, A. Hall Cdc42 regulates GSK-3beta and adenomatous polyposis coli to control cell polarity Nature 421 2003 753 756